Get all your news in one place.
100's of premium titles.
One app.
Start reading
Euronews
Euronews
Gabriela Galvin

New AI test could identify which patients could benefit from promising prostate cancer drug

A new artificial intelligence (AI) tool could boost health outcomes for some men with prostate cancer by identifying whether they would benefit from a promising treatment.

The drug abiraterone works by blocking testosterone production throughout the body, including in the tumour. 

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.